prof. dr. B. (Bob) Wilffert
Head of Department PharmacoTherapy, -Epidemiology and -Economics

Research
Research units:
1
Gebouw 3214, ruimte 0466
Groningen
Publications
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia
Loonen, A. J., Wilffert, B. & Ivanova, S. A., 5-Nov-2019, In : Pharmacogenomics.Research output: Contribution to journal › Article › Academic › peer-review
Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial)
van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Oude Voshaar, R. C., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J. & Wilffert, B., 7-Nov-2019, In : Journal of Clinical Psychopharmacology. 39, 6, p. 583-590 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines
Lunenburg, C. A. T. C., van der Wouden, C. H., Nijenhuis, M., Crommentuijn-van Rhenen, M. H., de Boer-Veger, N. J., Buunk, A. M., Houwink, E. J. F., Mulder, H., Rongen, G. A., van Schaik, R. H. N., van der Weide, J., Wilffert, B., Deneer, V. H. M., Swen, J. J. & Guchelaar, H-J., 19-Nov-2019, In : EJHG.Research output: Contribution to journal › Article › Academic › peer-review
Remarkable outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands, and factors associated with mortality and treatment default
Gafar, F., Boveneind-Vrubleuskaya, van 't, N., Akkerman, O., Wilffert, B. & Alffenaar, J-W., Nov-2019, In : International Journal of Tuberculosis and Lung Disease. 22, 11, p. S143 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
The effects of amoxicillin on acute COPD exacerbations in the outpatient setting: A retrospective cohort study based on real‐world data
Wang, Y., Bos, J., Schuiling-Veninga, C., Wilffert, B. & Hak, E., 2019, In : Pharmcoepidemiology and Drug Safety. 28, 52, 1208.Research output: Contribution to journal › Meeting Abstract › Academic
Press / Media
Meest Innovatieve geneesmiddelen. Medicatie voor borstkanker, spierziekte en reuma ‘bekroond’
22/12/2017
1 Media contribution
Press/Media: Expert Comment › Popular
Activities
Implementation of Pharmacogenetics in Clinical Practice.
Berend Wilffert (Invited speaker)23-Aug-2018 → 24-Aug-2018Activity: Talk or presentation › Professional
Implementation of Pharmacogenetics in Clinical Practice.
Berend Wilffert (Invited speaker)23-Aug-2018 → 25-Aug-2018Activity: Talk or presentation › Professional
Implementation of Pharmacogenetics in Pharmacotherapy of Chronic Diseases.
Berend Wilffert (Invited speaker)10-Aug-2018 → 11-Aug-2018Activity: Talk or presentation › Professional
Prizes
ID: 218810